1 Active Pharma Ingredient Market Overview 1.1 Active Pharma Ingredient Product Scope 1.2 Active Pharma Ingredient Segment by Type 1.2.1 Global Active Pharma Ingredient Sales by Type (2016 & 2021 & 2027) 1.2.2 Innovative Active Pharmaceutical Ingredients 1.2.3 Generic Active Pharmaceutical Ingredients 1.3 Active Pharma Ingredient Segment by Application 1.3.1 Global Active Pharma Ingredient Sales Comparison by Application (2016 & 2021 & 2027) 1.3.2 Oncology 1.3.3 Cardiovascular Disease 1.3.4 Diabetes 1.3.5 Central Nervous System and Neurological Disorders 1.3.6 Endocrinology 1.3.7 Other Therapeutic Applications 1.4 Active Pharma Ingredient Market Estimates and Forecasts (2016-2027) 1.4.1 Global Active Pharma Ingredient Market Size in Value Growth Rate (2016-2027) 1.4.2 Global Active Pharma Ingredient Market Size in Volume Growth Rate (2016-2027) 1.4.3 Global Active Pharma Ingredient Price Trends (2016-2027) 2 Active Pharma Ingredient Estimates and Forecasts by Region 2.1 Global Active Pharma Ingredient Market Size by Region: 2016 VS 2021 VS 2027 2.2 Global Active Pharma Ingredient Retrospective Market Scenario by Region (2016-2021) 2.2.1 Global Active Pharma Ingredient Sales Market Share by Region (2016-2021) 2.2.2 Global Active Pharma Ingredient Revenue Market Share by Region (2016-2021) 2.3 Global Active Pharma Ingredient Market Estimates and Forecasts by Region (2022-2027) 2.3.1 Global Active Pharma Ingredient Sales Estimates and Forecasts by Region (2022-2027) 2.3.2 Global Active Pharma Ingredient Revenue Forecast by Region (2022-2027) 2.4 Geographic Market Analysis: Market Facts & Figures 2.4.1 North America Active Pharma Ingredient Estimates and Projections (2016-2027) 2.4.2 Europe Active Pharma Ingredient Estimates and Projections (2016-2027) 2.4.3 China Active Pharma Ingredient Estimates and Projections (2016-2027) 2.4.4 Japan Active Pharma Ingredient Estimates and Projections (2016-2027) 2.4.5 Southeast Asia Active Pharma Ingredient Estimates and Projections (2016-2027) 2.4.6 India Active Pharma Ingredient Estimates and Projections (2016-2027) 3 Global Active Pharma Ingredient Competition Landscape by Players 3.1 Global Top Active Pharma Ingredient Players by Sales (2016-2021) 3.2 Global Top Active Pharma Ingredient Players by Revenue (2016-2021) 3.3 Global Active Pharma Ingredient Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Active Pharma Ingredient as of 2020) 3.4 Global Active Pharma Ingredient Average Price by Company (2016-2021) 3.5 Manufacturers Active Pharma Ingredient Manufacturing Sites, Area Served, Product Type 3.6 Manufacturers Mergers & Acquisitions, Expansion Plans 4 Global Active Pharma Ingredient Market Size by Type 4.1 Global Active Pharma Ingredient Historic Market Review by Type (2016-2021) 4.1.1 Global Active Pharma Ingredient Sales Market Share by Type (2016-2021) 4.1.2 Global Active Pharma Ingredient Revenue Market Share by Type (2016-2021) 4.1.3 Global Active Pharma Ingredient Price by Type (2016-2021) 4.2 Global Active Pharma Ingredient Market Estimates and Forecasts by Type (2022-2027) 4.2.1 Global Active Pharma Ingredient Sales Forecast by Type (2022-2027) 4.2.2 Global Active Pharma Ingredient Revenue Forecast by Type (2022-2027) 4.2.3 Global Active Pharma Ingredient Price Forecast by Type (2022-2027) 5 Global Active Pharma Ingredient Market Size by Application 5.1 Global Active Pharma Ingredient Historic Market Review by Application (2016-2021) 5.1.1 Global Active Pharma Ingredient Sales Market Share by Application (2016-2021) 5.1.2 Global Active Pharma Ingredient Revenue Market Share by Application (2016-2021) 5.1.3 Global Active Pharma Ingredient Price by Application (2016-2021) 5.2 Global Active Pharma Ingredient Market Estimates and Forecasts by Application (2022-2027) 5.2.1 Global Active Pharma Ingredient Sales Forecast by Application (2022-2027) 5.2.2 Global Active Pharma Ingredient Revenue Forecast by Application (2022-2027) 5.2.3 Global Active Pharma Ingredient Price Forecast by Application (2022-2027) 6 North America Active Pharma Ingredient Market Facts & Figures 6.1 North America Active Pharma Ingredient Sales by Company 6.1.1 North America Active Pharma Ingredient Sales by Company (2016-2021) 6.1.2 North America Active Pharma Ingredient Revenue by Company (2016-2021) 6.2 North America Active Pharma Ingredient Sales Breakdown by Type 6.2.1 North America Active Pharma Ingredient Sales Breakdown by Type (2016-2021) 6.2.2 North America Active Pharma Ingredient Sales Breakdown by Type (2022-2027) 6.3 North America Active Pharma Ingredient Sales Breakdown by Application 6.3.1 North America Active Pharma Ingredient Sales Breakdown by Application (2016-2021) 6.3.2 North America Active Pharma Ingredient Sales Breakdown by Application (2022-2027) 7 Europe Active Pharma Ingredient Market Facts & Figures 7.1 Europe Active Pharma Ingredient Sales by Company 7.1.1 Europe Active Pharma Ingredient Sales by Company (2016-2021) 7.1.2 Europe Active Pharma Ingredient Revenue by Company (2016-2021) 7.2 Europe Active Pharma Ingredient Sales Breakdown by Type 7.2.1 Europe Active Pharma Ingredient Sales Breakdown by Type (2016-2021) 7.2.2 Europe Active Pharma Ingredient Sales Breakdown by Type (2022-2027) 7.3 Europe Active Pharma Ingredient Sales Breakdown by Application 7.3.1 Europe 145 Sales Breakdown by Application (2016-2021) 7.3.2 Europe 145 Sales Breakdown by Application (2022-2027) 8 China Active Pharma Ingredient Market Facts & Figures 8.1 China Active Pharma Ingredient Sales by Company 8.1.1 China Active Pharma Ingredient Sales by Company (2016-2021) 8.1.2 China Active Pharma Ingredient Revenue by Company (2016-2021) 8.2 China Active Pharma Ingredient Sales Breakdown by Type 8.2.1 China Active Pharma Ingredient Sales Breakdown by Type (2016-2021) 8.2.2 China Active Pharma Ingredient Sales Breakdown by Type (2022-2027) 8.3 China Active Pharma Ingredient Sales Breakdown by Application 8.3.1 China 174 Sales Breakdown by Application (2016-2021) 8.3.2 China 174 Sales Breakdown by Application (2022-2027) 9 Japan Active Pharma Ingredient Market Facts & Figures 9.1 Japan Active Pharma Ingredient Sales by Company 9.1.1 Japan Active Pharma Ingredient Sales by Company (2016-2021) 9.1.2 Japan Active Pharma Ingredient Revenue by Company (2016-2021) 9.2 Japan Active Pharma Ingredient Sales Breakdown by Type 9.2.1 Japan Active Pharma Ingredient Sales Breakdown by Type (2016-2021) 9.2.2 Japan Active Pharma Ingredient Sales Breakdown by Type (2022-2027) 9.3 Japan Active Pharma Ingredient Sales Breakdown by Application 9.3.1 Japan Feb. Sales Breakdown by Application (2016-2021) 9.3.2 Japan Feb. Sales Breakdown by Application (2022-2027) 10 Southeast Asia Active Pharma Ingredient Market Facts & Figures 10.1 Southeast Asia Active Pharma Ingredient Sales by Company 10.1.1 Southeast Asia Active Pharma Ingredient Sales by Company (2016-2021) 10.1.2 Southeast Asia Active Pharma Ingredient Revenue by Company (2016-2021) 10.2 Southeast Asia Active Pharma Ingredient Sales Breakdown by Type 10.2.1 Southeast Asia Active Pharma Ingredient Sales Breakdown by Type (2016-2021) 10.2.2 Southeast Asia Active Pharma Ingredient Sales Breakdown by Type (2022-2027) 10.3 Southeast Asia Active Pharma Ingredient Sales Breakdown by Application 10.3.1 Southeast Asia K Pcs Sales Breakdown by Application (2016-2021) 10.3.2 Southeast Asia K Pcs Sales Breakdown by Application (2022-2027) 11 India Active Pharma Ingredient Market Facts & Figures 11.1 India Active Pharma Ingredient Sales by Company 11.1.1 India Active Pharma Ingredient Sales by Company (2016-2021) 11.1.2 India Active Pharma Ingredient Revenue by Company (2016-2021) 11.2 India Active Pharma Ingredient Sales Breakdown by Type 11.2.1 India Active Pharma Ingredient Sales Breakdown by Type (2016-2021) 11.2.2 India Active Pharma Ingredient Sales Breakdown by Type (2022-2027) 11.3 India Active Pharma Ingredient Sales Breakdown by Application 11.3.1 India Active Pharma Ingredient Sales Breakdown by Application (2016-2021) 11.3.2 India Active Pharma Ingredient Sales Breakdown by Application (2022-2027) 12 Company Profiles and Key Figures in Active Pharma Ingredient Business 12.1 Teva 12.1.1 Teva Corporation Information 12.1.2 Teva Business Overview 12.1.3 Teva Active Pharma Ingredient Sales, Revenue and Gross Margin (2016-2021) 12.1.4 Teva Active Pharma Ingredient Products Offered 12.1.5 Teva Recent Development 12.2 Novartis 12.2.1 Novartis Corporation Information 12.2.2 Novartis Business Overview 12.2.3 Novartis Active Pharma Ingredient Sales, Revenue and Gross Margin (2016-2021) 12.2.4 Novartis Active Pharma Ingredient Products Offered 12.2.5 Novartis Recent Development 12.3 Pfizer 12.3.1 Pfizer Corporation Information 12.3.2 Pfizer Business Overview 12.3.3 Pfizer Active Pharma Ingredient Sales, Revenue and Gross Margin (2016-2021) 12.3.4 Pfizer Active Pharma Ingredient Products Offered 12.3.5 Pfizer Recent Development 12.4 Johnson & Johnson 12.4.1 Johnson & Johnson Corporation Information 12.4.2 Johnson & Johnson Business Overview 12.4.3 Johnson & Johnson Active Pharma Ingredient Sales, Revenue and Gross Margin (2016-2021) 12.4.4 Johnson & Johnson Active Pharma Ingredient Products Offered 12.4.5 Johnson & Johnson Recent Development 12.5 Mylan 12.5.1 Mylan Corporation Information 12.5.2 Mylan Business Overview 12.5.3 Mylan Active Pharma Ingredient Sales, Revenue and Gross Margin (2016-2021) 12.5.4 Mylan Active Pharma Ingredient Products Offered 12.5.5 Mylan Recent Development 12.6 North China Pharmaceutical Group 12.6.1 North China Pharmaceutical Group Corporation Information 12.6.2 North China Pharmaceutical Group Business Overview 12.6.3 North China Pharmaceutical Group Active Pharma Ingredient Sales, Revenue and Gross Margin (2016-2021) 12.6.4 North China Pharmaceutical Group Active Pharma Ingredient Products Offered 12.6.5 North China Pharmaceutical Group Recent Development 12.7 Dr. Reddy’s Laboratories 12.7.1 Dr. Reddy’s Laboratories Corporation Information 12.7.2 Dr. Reddy’s Laboratories Business Overview 12.7.3 Dr. Reddy’s Laboratories Active Pharma Ingredient Sales, Revenue and Gross Margin (2016-2021) 12.7.4 Dr. Reddy’s Laboratories Active Pharma Ingredient Products Offered 12.7.5 Dr. Reddy’s Laboratories Recent Development 12.8 Roche 12.8.1 Roche Corporation Information 12.8.2 Roche Business Overview 12.8.3 Roche Active Pharma Ingredient Sales, Revenue and Gross Margin (2016-2021) 12.8.4 Roche Active Pharma Ingredient Products Offered 12.8.5 Roche Recent Development 12.9 Aurobindo pharma 12.9.1 Aurobindo pharma Corporation Information 12.9.2 Aurobindo pharma Business Overview 12.9.3 Aurobindo pharma Active Pharma Ingredient Sales, Revenue and Gross Margin (2016-2021) 12.9.4 Aurobindo pharma Active Pharma Ingredient Products Offered 12.9.5 Aurobindo pharma Recent Development 12.10 Sun Pharmaceutical Industries 12.10.1 Sun Pharmaceutical Industries Corporation Information 12.10.2 Sun Pharmaceutical Industries Business Overview 12.10.3 Sun Pharmaceutical Industries Active Pharma Ingredient Sales, Revenue and Gross Margin (2016-2021) 12.10.4 Sun Pharmaceutical Industries Active Pharma Ingredient Products Offered 12.10.5 Sun Pharmaceutical Industries Recent Development 12.11 Boehringer Ingelheim GmbH 12.11.1 Boehringer Ingelheim GmbH Corporation Information 12.11.2 Boehringer Ingelheim GmbH Business Overview 12.11.3 Boehringer Ingelheim GmbH Active Pharma Ingredient Sales, Revenue and Gross Margin (2016-2021) 12.11.4 Boehringer Ingelheim GmbH Active Pharma Ingredient Products Offered 12.11.5 Boehringer Ingelheim GmbH Recent Development 12.12 Bayer 12.12.1 Bayer Corporation Information 12.12.2 Bayer Business Overview 12.12.3 Bayer Active Pharma Ingredient Sales, Revenue and Gross Margin (2016-2021) 12.12.4 Bayer Active Pharma Ingredient Products Offered 12.12.5 Bayer Recent Development 12.13 BASF 12.13.1 BASF Corporation Information 12.13.2 BASF Business Overview 12.13.3 BASF Active Pharma Ingredient Sales, Revenue and Gross Margin (2016-2021) 12.13.4 BASF Active Pharma Ingredient Products Offered 12.13.5 BASF Recent Development 12.14 DSM 12.14.1 DSM Corporation Information 12.14.2 DSM Business Overview 12.14.3 DSM Active Pharma Ingredient Sales, Revenue and Gross Margin (2016-2021) 12.14.4 DSM Active Pharma Ingredient Products Offered 12.14.5 DSM Recent Development 12.15 Zhejiang Medicine 12.15.1 Zhejiang Medicine Corporation Information 12.15.2 Zhejiang Medicine Business Overview 12.15.3 Zhejiang Medicine Active Pharma Ingredient Sales, Revenue and Gross Margin (2016-2021) 12.15.4 Zhejiang Medicine Active Pharma Ingredient Products Offered 12.15.5 Zhejiang Medicine Recent Development 12.16 Biocon 12.16.1 Biocon Corporation Information 12.16.2 Biocon Business Overview 12.16.3 Biocon Active Pharma Ingredient Sales, Revenue and Gross Margin (2016-2021) 12.16.4 Biocon Active Pharma Ingredient Products Offered 12.16.5 Biocon Recent Development 12.17 Johnson Matthey 12.17.1 Johnson Matthey Corporation Information 12.17.2 Johnson Matthey Business Overview 12.17.3 Johnson Matthey Active Pharma Ingredient Sales, Revenue and Gross Margin (2016-2021) 12.17.4 Johnson Matthey Active Pharma Ingredient Products Offered 12.17.5 Johnson Matthey Recent Development 12.18 Hisun Pharmacy 12.18.1 Hisun Pharmacy Corporation Information 12.18.2 Hisun Pharmacy Business Overview 12.18.3 Hisun Pharmacy Active Pharma Ingredient Sales, Revenue and Gross Margin (2016-2021) 12.18.4 Hisun Pharmacy Active Pharma Ingredient Products Offered 12.18.5 Hisun Pharmacy Recent Development 12.19 Cambrex 12.19.1 Cambrex Corporation Information 12.19.2 Cambrex Business Overview 12.19.3 Cambrex Active Pharma Ingredient Sales, Revenue and Gross Margin (2016-2021) 12.19.4 Cambrex Active Pharma Ingredient Products Offered 12.19.5 Cambrex Recent Development 12.20 Shandong Xinhua Pharmaceutical 12.20.1 Shandong Xinhua Pharmaceutical Corporation Information 12.20.2 Shandong Xinhua Pharmaceutical Business Overview 12.20.3 Shandong Xinhua Pharmaceutical Active Pharma Ingredient Sales, Revenue and Gross Margin (2016-2021) 12.20.4 Shandong Xinhua Pharmaceutical Active Pharma Ingredient Products Offered 12.20.5 Shandong Xinhua Pharmaceutical Recent Development 12.21 Lonza group 12.21.1 Lonza group Corporation Information 12.21.2 Lonza group Business Overview 12.21.3 Lonza group Active Pharma Ingredient Sales, Revenue and Gross Margin (2016-2021) 12.21.4 Lonza group Active Pharma Ingredient Products Offered 12.21.5 Lonza group Recent Development 12.22 Huahai Pharmaceutical 12.22.1 Huahai Pharmaceutical Corporation Information 12.22.2 Huahai Pharmaceutical Business Overview 12.22.3 Huahai Pharmaceutical Active Pharma Ingredient Sales, Revenue and Gross Margin (2016-2021) 12.22.4 Huahai Pharmaceutical Active Pharma Ingredient Products Offered 12.22.5 Huahai Pharmaceutical Recent Development 12.23 Haerbin Pharmaceutical Group 12.23.1 Haerbin Pharmaceutical Group Corporation Information 12.23.2 Haerbin Pharmaceutical Group Business Overview 12.23.3 Haerbin Pharmaceutical Group Active Pharma Ingredient Sales, Revenue and Gross Margin (2016-2021) 12.23.4 Haerbin Pharmaceutical Group Active Pharma Ingredient Products Offered 12.23.5 Haerbin Pharmaceutical Group Recent Development 12.24 Cipla 12.24.1 Cipla Corporation Information 12.24.2 Cipla Business Overview 12.24.3 Cipla Active Pharma Ingredient Sales, Revenue and Gross Margin (2016-2021) 12.24.4 Cipla Active Pharma Ingredient Products Offered 12.24.5 Cipla Recent Development 12.25 Tian Yao 12.25.1 Tian Yao Corporation Information 12.25.2 Tian Yao Business Overview 12.25.3 Tian Yao Active Pharma Ingredient Sales, Revenue and Gross Margin (2016-2021) 12.25.4 Tian Yao Active Pharma Ingredient Products Offered 12.25.5 Tian Yao Recent Development 12.26 Lupin 12.26.1 Lupin Corporation Information 12.26.2 Lupin Business Overview 12.26.3 Lupin Active Pharma Ingredient Sales, Revenue and Gross Margin (2016-2021) 12.26.4 Lupin Active Pharma Ingredient Products Offered 12.26.5 Lupin Recent Development 12.27 North East Pharmaceutical 12.27.1 North East Pharmaceutical Corporation Information 12.27.2 North East Pharmaceutical Business Overview 12.27.3 North East Pharmaceutical Active Pharma Ingredient Sales, Revenue and Gross Margin (2016-2021) 12.27.4 North East Pharmaceutical Active Pharma Ingredient Products Offered 12.27.5 North East Pharmaceutical Recent Development 12.28 Albemarle 12.28.1 Albemarle Corporation Information 12.28.2 Albemarle Business Overview 12.28.3 Albemarle Active Pharma Ingredient Sales, Revenue and Gross Margin (2016-2021) 12.28.4 Albemarle Active Pharma Ingredient Products Offered 12.28.5 Albemarle Recent Development 12.29 Shandong Lukang Pharmaceutical 12.29.1 Shandong Lukang Pharmaceutical Corporation Information 12.29.2 Shandong Lukang Pharmaceutical Business Overview 12.29.3 Shandong Lukang Pharmaceutical Active Pharma Ingredient Sales, Revenue and Gross Margin (2016-2021) 12.29.4 Shandong Lukang Pharmaceutical Active Pharma Ingredient Products Offered 12.29.5 Shandong Lukang Pharmaceutical Recent Development 12.30 Jiangsu Hengrui Medicine 12.30.1 Jiangsu Hengrui Medicine Corporation Information 12.30.2 Jiangsu Hengrui Medicine Business Overview 12.30.3 Jiangsu Hengrui Medicine Active Pharma Ingredient Sales, Revenue and Gross Margin (2016-2021) 12.30.4 Jiangsu Hengrui Medicine Active Pharma Ingredient Products Offered 12.30.5 Jiangsu Hengrui Medicine Recent Development 13 Active Pharma Ingredient Manufacturing Cost Analysis 13.1 Active Pharma Ingredient Key Raw Materials Analysis 13.1.1 Key Raw Materials 13.1.2 Key Raw Materials Price Trend 13.1.3 Key Suppliers of Raw Materials 13.2 Proportion of Manufacturing Cost Structure 13.3 Manufacturing Process Analysis of Active Pharma Ingredient 13.4 Active Pharma Ingredient Industrial Chain Analysis 14 Marketing Channel, Distributors and Customers 14.1 Marketing Channel 14.2 Active Pharma Ingredient Distributors List 14.3 Active Pharma Ingredient Customers 15 Market Dynamics 15.1 Active Pharma Ingredient Market Trends 15.2 Active Pharma Ingredient Drivers 15.3 Active Pharma Ingredient Market Challenges 15.4 Active Pharma Ingredient Market Restraints 16 Research Findings and Conclusion 17 Appendix 17.1 Research Methodology 17.1.1 Methodology/Research Approach 17.1.2 Data Source 17.2 Author List 17.3 Disclaimer

List of Tables Table 1. Global Active Pharma Ingredient Sales (US$ Million) Growth Rate by Type (2016 & 2021 & 2027) Table 2. Global Active Pharma Ingredient Sales ((US$ Million)) Comparison by Application (2016 & 2021 & 2027) Table 3. Global Active Pharma Ingredient Market Size (US$ Million) by Region: 2016 VS 2021 &2027 Table 4. Global Active Pharma Ingredient Sales (K Pcs) by Region (2016-2021) Table 5. Global Active Pharma Ingredient Sales Market Share by Region (2016-2021) Table 6. Global Active Pharma Ingredient Revenue (US$ Million) Market Share by Region (2016-2021)) Table 7. Global Active Pharma Ingredient Revenue Share by Region (2016-2021) Table 8. Global Active Pharma Ingredient Sales (K Pcs) Forecast by Region (2022-2027) Table 9. Global Active Pharma Ingredient Sales Market Share Forecast by Region (2022-2027) Table 10. Global Active Pharma Ingredient Revenue (US$ Million) Forecast by Region (2022-2027) Table 11. Global Active Pharma Ingredient Revenue Share Forecast by Region (2022-2027) Table 12. Global Active Pharma Ingredient Sales (K Pcs) of Key Companies (2016-2021) Table 13. Global Active Pharma Ingredient Sales Share by Company (2016-2021) Table 14. Global Active Pharma Ingredient Revenue (US$ Million) by Company (2016-2021) Table 15. Global Active Pharma Ingredient Revenue Share by Company (2016-2021) Table 16. Global Active Pharma Ingredient by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Active Pharma Ingredient as of 2020) Table 17. Global Active Pharma Ingredient Average Price (USD/Pcs) of Key Company (2016-2021) Table 18. Manufacturers Active Pharma Ingredient Manufacturing Sites and Area Served Table 19. Manufacturers Active Pharma Ingredient Product Type Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans Table 21. Global Active Pharma Ingredient Sales (K Pcs) by Type (2016-2021) Table 22. Global Active Pharma Ingredient Sales Share by Type (2016-2021) Table 23. Global Active Pharma Ingredient Revenue (US$ Million) Market Share by Type (2016-2021) Table 24. Global Active Pharma Ingredient Price (USD/Pcs) by Type (2016-2021) Table 25. Global Active Pharma Ingredient Sales Share by Type (2022-2027) Table 26. Global Active Pharma Ingredient Revenue (US$ Million) Market Share by Type (2022-2027) Table 27. Global Active Pharma Ingredient Revenue Share by Type (2022-2027) Table 28. Global Active Pharma Ingredient Price (USD/Pcs) by Type (2022-2027) Table 29. Global Active Pharma Ingredient Sales (K Pcs) by Application (2016-2021) Table 30. Global Active Pharma Ingredient Sales Share by Application (2016-2021) Table 31. Global Active Pharma Ingredient Revenue (US$ Million) Market Share by Application (2016-2021) Table 32. Global Active Pharma Ingredient Price (USD/Pcs) by Application (2016-2021) Table 33. Global Active Pharma Ingredient Sales (K Pcs) by Application (2022-2027) Table 34. Global Active Pharma Ingredient Sales Share by Application (2022-2027) Table 35. Global Active Pharma Ingredient Revenue (US$ Million) Market Share by Application (2022-2027) Table 36. Global Active Pharma Ingredient Revenue Share by Application (2022-2027) Table 37. Global Active Pharma Ingredient Price (USD/Pcs) by Application (2022-2027) Table 38. North America Active Pharma Ingredient Sales (K Pcs) by Company (2016-2021) Table 39. North America Active Pharma Ingredient Sales Market Share by Company (2016-2021) Table 40. North America Active Pharma Ingredient Revenue by Company (2016-2021) & (US$ Million) Table 41. North America Active Pharma Ingredient Revenue Market Share by Company (2016-2021) Table 42. North America Active Pharma Ingredient Sales by Type (2016-2021) & (K Pcs) Table 43. North America Active Pharma Ingredient Sales Market Share by Type (2016-2021) Table 44. North America Active Pharma Ingredient Sales by Type (2022-2027) & (K Pcs) Table 45. North America Active Pharma Ingredient Sales Market Share by Type (2022-2027) Table 46. North America Active Pharma Ingredient Sales by Application (2016-2021) & (K Pcs) Table 47. North America Active Pharma Ingredient Sales Market Share by Application (2016-2021) Table 48. North America Active Pharma Ingredient Sales by Application (2022-2027) & (K Pcs) Table 49. North America Active Pharma Ingredient Sales Market Share by Application (2022-2027) Table 50. Europe Active Pharma Ingredient Sales (K Pcs) by Company (2016-2021) Table 51. Europe Active Pharma Ingredient Sales Market Share by Company (2016-2021) Table 52. Europe Active Pharma Ingredient Revenue by Company (2016-2021) & (US$ Million) Table 53. Europe Active Pharma Ingredient Revenue Market Share by Company (2016-2021) Table 54. Europe Active Pharma Ingredient Sales by Type (2016-2021) & (K Pcs) Table 55. Europe Active Pharma Ingredient Sales Market Share by Type (2016-2021) Table 56. Europe Active Pharma Ingredient Sales by Type (2022-2027) & (K Pcs) Table 57. Europe Active Pharma Ingredient Sales Market Share by Type (2022-2027) Table 58. Europe Active Pharma Ingredient Sales by Application (2016-2021) & (K Pcs) Table 59. Europe Active Pharma Ingredient Sales Market Share by Application (2016-2021) Table 60. Europe Active Pharma Ingredient Sales by Application (2022-2027) & (K Pcs) Table 61. Europe Active Pharma Ingredient Sales Market Share by Application (2022-2027) Table 62. China Active Pharma Ingredient Sales (K Pcs) by Company (2016-2021) Table 63. China Active Pharma Ingredient Sales Market Share by Company (2016-2021) Table 64. China Active Pharma Ingredient Revenue by Company (2016-2021) & (US$ Million) Table 65. China Active Pharma Ingredient Revenue Market Share by Company (2016-2021) Table 66. China Active Pharma Ingredient Sales by Type (2016-2021) & (K Pcs) Table 67. China Active Pharma Ingredient Sales Market Share by Type (2016-2021) Table 68. China Active Pharma Ingredient Sales by Type (2022-2027) & (K Pcs) Table 69. China Active Pharma Ingredient Sales Market Share by Type (2022-2027) Table 70. China Active Pharma Ingredient Sales by Application (2016-2021) & (K Pcs) Table 71. China Active Pharma Ingredient Sales Market Share by Application (2016-2021) Table 72. China Active Pharma Ingredient Sales by Application (2022-2027) & (K Pcs) Table 73. China Active Pharma Ingredient Sales Market Share by Application (2022-2027) Table 74. Japan Active Pharma Ingredient Sales (K Pcs) by Company (2016-2021) Table 75. Japan Active Pharma Ingredient Sales Market Share by Company (2016-2021) Table 76. Japan Active Pharma Ingredient Revenue by Company (2016-2021) & (US$ Million) Table 77. Japan Active Pharma Ingredient Revenue Market Share by Company (2016-2021) Table 78. Japan Active Pharma Ingredient Sales by Type (2016-2021) & (K Pcs) Table 79. Japan Active Pharma Ingredient Sales Market Share by Type (2016-2021) Table 80. Japan Active Pharma Ingredient Sales by Type (2022-2027) & (K Pcs) Table 81. Japan Active Pharma Ingredient Sales Market Share by Type (2022-2027) Table 82. Japan Active Pharma Ingredient Sales by Application (2016-2021) & (K Pcs) Table 83. Japan Active Pharma Ingredient Sales Market Share by Application (2016-2021) Table 84. Japan Active Pharma Ingredient Sales by Application (2022-2027) & (K Pcs) Table 85. Japan Active Pharma Ingredient Sales Market Share by Application (2022-2027) Table 86. Southeast Asia Active Pharma Ingredient Sales (K Pcs) by Company (2016-2021) Table 87. Southeast Asia Active Pharma Ingredient Sales Market Share by Company (2016-2021) Table 88. Southeast Asia Active Pharma Ingredient Revenue by Company (2016-2021) & (US$ Million) Table 89. Southeast Asia Active Pharma Ingredient Revenue Market Share by Company (2016-2021) Table 90. Southeast Asia Active Pharma Ingredient Sales by Type (2016-2021) & (K Pcs) Table 91. Southeast Asia Active Pharma Ingredient Sales Market Share by Type (2016-2021) Table 92. Southeast Asia Active Pharma Ingredient Sales by Type (2022-2027) & (K Pcs) Table 93. Southeast Asia Active Pharma Ingredient Sales Market Share by Type (2022-2027) Table 94. Southeast Asia Active Pharma Ingredient Sales by Application (2016-2021) & (K Pcs) Table 95. Southeast Asia Active Pharma Ingredient Sales Market Share by Application (2016-2021) Table 96. Southeast Asia Active Pharma Ingredient Sales by Application (2022-2027) & (K Pcs) Table 97. Southeast Asia Active Pharma Ingredient Sales Market Share by Application (2022-2027) Table 98. India Active Pharma Ingredient Sales (K Pcs) by Company (2016-2021) Table 99. India Active Pharma Ingredient Sales Market Share by Company (2016-2021) Table 100. India Active Pharma Ingredient Revenue by Company (2016-2021) & (US$ Million) Table 101. India Active Pharma Ingredient Revenue Market Share by Company (2016-2021) Table 102. India Active Pharma Ingredient Sales by Type (2016-2021) & (K Pcs) Table 103. India Active Pharma Ingredient Sales Market Share by Type (2016-2021) Table 104. India Active Pharma Ingredient Sales by Type (2022-2027) & (K Pcs) Table 105. India Active Pharma Ingredient Sales Market Share by Type (2022-2027) Table 106. India Active Pharma Ingredient Sales by Application (2016-2021) & (K Pcs) Table 107. India Active Pharma Ingredient Sales Market Share by Application (2016-2021) Table 108. India Active Pharma Ingredient Sales by Application (2022-2027) & (K Pcs) Table 109. India Active Pharma Ingredient Sales Market Share by Application (2022-2027) Table 110. Teva Corporation Information Table 111. Teva Description and Business Overview Table 112. Teva Active Pharma Ingredient Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021) Table 113. Teva Active Pharma Ingredient Product Table 114. Teva Recent Development Table 115. Novartis Corporation Information Table 116. Novartis Description and Business Overview Table 117. Novartis Active Pharma Ingredient Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021) Table 118. Novartis Active Pharma Ingredient Product Table 119. Novartis Recent Development Table 120. Pfizer Corporation Information Table 121. Pfizer Description and Business Overview Table 122. Pfizer Active Pharma Ingredient Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021) Table 123. Pfizer Active Pharma Ingredient Product Table 124. Pfizer Recent Development Table 125. Johnson & Johnson Corporation Information Table 126. Johnson & Johnson Description and Business Overview Table 127. Johnson & Johnson Active Pharma Ingredient Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021) Table 128. Johnson & Johnson Active Pharma Ingredient Product Table 129. Johnson & Johnson Recent Development Table 130. Mylan Corporation Information Table 131. Mylan Description and Business Overview Table 132. Mylan Active Pharma Ingredient Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021) Table 133. Mylan Active Pharma Ingredient Product Table 134. Mylan Recent Development Table 135. North China Pharmaceutical Group Corporation Information Table 136. North China Pharmaceutical Group Description and Business Overview Table 137. North China Pharmaceutical Group Active Pharma Ingredient Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021) Table 138. North China Pharmaceutical Group Active Pharma Ingredient Product Table 139. North China Pharmaceutical Group Recent Development Table 140. Dr. Reddy’s Laboratories Corporation Information Table 141. Dr. Reddy’s Laboratories Description and Business Overview Table 142. Dr. Reddy’s Laboratories Active Pharma Ingredient Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021) Table 143. Dr. Reddy’s Laboratories Active Pharma Ingredient Product Table 144. Dr. Reddy’s Laboratories Recent Development Table 145. Roche Corporation Information Table 146. Roche Active Pharma Ingredient Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021) Table 147. Roche Description and Business Overview Table 148. Roche Active Pharma Ingredient Product Table 149. Roche Recent Development Table 150. Aurobindo pharma Corporation Information Table 151. Aurobindo pharma Active Pharma Ingredient Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021) Table 152. Aurobindo pharma Description and Business Overview Table 153. Aurobindo pharma Active Pharma Ingredient Product Table 154. Aurobindo pharma Recent Development Table 155. Sun Pharmaceutical Industries Corporation Information Table 156. Sun Pharmaceutical Industries Description and Business Overview Table 157. Sun Pharmaceutical Industries Active Pharma Ingredient Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021) Table 158. Sun Pharmaceutical Industries Active Pharma Ingredient Product Table 159. Sun Pharmaceutical Industries Recent Development Table 160. Boehringer Ingelheim GmbH Corporation Information Table 161. Boehringer Ingelheim GmbH Description and Business Overview Table 162. Boehringer Ingelheim GmbH Active Pharma Ingredient Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021) Table 163. Boehringer Ingelheim GmbH Active Pharma Ingredient Product Table 164. Boehringer Ingelheim GmbH Recent Development Table 165. Bayer Corporation Information Table 166. Bayer Description and Business Overview Table 167. Bayer Active Pharma Ingredient Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021) Table 168. Bayer Active Pharma Ingredient Product Table 169. Bayer Recent Development Table 170. BASF Corporation Information Table 171. BASF Description and Business Overview Table 172. BASF Active Pharma Ingredient Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021) Table 173. BASF Active Pharma Ingredient Product Table 174. BASF Recent Development Table 175. DSM Corporation Information Table 176. DSM Description and Business Overview Table 177. DSM Active Pharma Ingredient Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021) Table 178. DSM Active Pharma Ingredient Product Table 179. DSM Recent Development Table 180. Zhejiang Medicine Corporation Information Table 181. Zhejiang Medicine Description and Business Overview Table 182. Zhejiang Medicine Active Pharma Ingredient Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021) Table 183. Zhejiang Medicine Active Pharma Ingredient Product Table 184. Zhejiang Medicine Recent Development Table 185. Biocon Corporation Information Table 186. Biocon Description and Business Overview Table 187. Biocon Active Pharma Ingredient Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021) Table 188. Biocon Active Pharma Ingredient Product Table 189. Biocon Recent Development Table 190. Johnson Matthey Corporation Information Table 191. Johnson Matthey Description and Business Overview Table 192. Johnson Matthey Active Pharma Ingredient Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021) Table 193. Johnson Matthey Active Pharma Ingredient Product Table 194. Johnson Matthey Recent Development Table 195. Hisun Pharmacy Corporation Information Table 196. Hisun Pharmacy Description and Business Overview Table 197. Hisun Pharmacy Active Pharma Ingredient Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021) Table 198. Hisun Pharmacy Active Pharma Ingredient Product Table 199. Hisun Pharmacy Recent Development Table 200. Cambrex Corporation Information Table 201. Cambrex Description and Business Overview Table 202. Cambrex Active Pharma Ingredient Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021) Table 203. Cambrex Active Pharma Ingredient Product Table 204. Cambrex Recent Development Table 205. Shandong Xinhua Pharmaceutical Corporation Information Table 206. Shandong Xinhua Pharmaceutical Description and Business Overview Table 207. Shandong Xinhua Pharmaceutical Active Pharma Ingredient Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021) Table 208. Shandong Xinhua Pharmaceutical Active Pharma Ingredient Product Table 209. Shandong Xinhua Pharmaceutical Recent Development Table 210. Lonza group Corporation Information Table 211. Lonza group Description and Business Overview Table 212. Lonza group Active Pharma Ingredient Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021) Table 213. Lonza group Active Pharma Ingredient Product Table 214. Lonza group Recent Development Table 215. Huahai Pharmaceutical Corporation Information Table 216. Huahai Pharmaceutical Description and Business Overview Table 217. Huahai Pharmaceutical Active Pharma Ingredient Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021) Table 218. Huahai Pharmaceutical Active Pharma Ingredient Product Table 219. Huahai Pharmaceutical Recent Development Table 220. Haerbin Pharmaceutical Group Corporation Information Table 221. Haerbin Pharmaceutical Group Description and Business Overview Table 222. Haerbin Pharmaceutical Group Active Pharma Ingredient Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021) Table 223. Haerbin Pharmaceutical Group Active Pharma Ingredient Product Table 224. Haerbin Pharmaceutical Group Recent Development Table 225. Cipla Corporation Information Table 226. Cipla Description and Business Overview Table 227. Cipla Active Pharma Ingredient Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021) Table 228. Cipla Active Pharma Ingredient Product Table 229. Cipla Recent Development Table 230. Tian Yao Corporation Information Table 231. Tian Yao Description and Business Overview Table 232. Tian Yao Active Pharma Ingredient Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021) Table 233. Tian Yao Active Pharma Ingredient Product Table 234. Tian Yao Recent Development Table 235. Lupin Corporation Information Table 236. Lupin Description and Business Overview Table 237. Lupin Active Pharma Ingredient Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021) Table 238. Lupin Active Pharma Ingredient Product Table 239. Lupin Recent Development Table 240. North East Pharmaceutical Corporation Information Table 241. North East Pharmaceutical Description and Business Overview Table 242. North East Pharmaceutical Active Pharma Ingredient Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021) Table 243. North East Pharmaceutical Active Pharma Ingredient Product Table 244. North East Pharmaceutical Recent Development Table 245. Albemarle Corporation Information Table 246. Albemarle Description and Business Overview Table 247. Albemarle Active Pharma Ingredient Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021) Table 248. Albemarle Active Pharma Ingredient Product Table 249. Albemarle Recent Development Table 250. Shandong Lukang Pharmaceutical Corporation Information Table 251. Shandong Lukang Pharmaceutical Description and Business Overview Table 252. Shandong Lukang Pharmaceutical Active Pharma Ingredient Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021) Table 253. Shandong Lukang Pharmaceutical Active Pharma Ingredient Product Table 254. Shandong Lukang Pharmaceutical Recent Development Table 255. Jiangsu Hengrui Medicine Corporation Information Table 256. Jiangsu Hengrui Medicine Description and Business Overview Table 257. Jiangsu Hengrui Medicine Active Pharma Ingredient Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2016-2021) Table 258. Jiangsu Hengrui Medicine Active Pharma Ingredient Product Table 259. Jiangsu Hengrui Medicine Recent Development Table 260. Production Base and Market Concentration Rate of Raw Material Table 261. Key Suppliers of Raw Materials Table 262. Active Pharma Ingredient Distributors List Table 263. Active Pharma Ingredient Customers List Table 264. Active Pharma Ingredient Market Trends Table 265. Active Pharma Ingredient Market Drivers Table 266. Active Pharma Ingredient Market Challenges Table 267. Active Pharma Ingredient Market Restraints Table 268. Research Programs/Design for This Report Table 269. Key Data Information from Secondary Sources Table 270. Key Data Information from Primary Sources List of Figures Figure 1. Active Pharma Ingredient Product Picture Figure 2. Global Active Pharma Ingredient Sales Market Share by Type in 2021 & 2027 Figure 3. Innovative Active Pharmaceutical Ingredients Product Picture Figure 4. Generic Active Pharmaceutical Ingredients Product Picture Figure 5. Global Active Pharma Ingredient Sales Market Share by Application in 2021 & 2027 Figure 6. Oncology Examples Figure 7. Cardiovascular Disease Examples Figure 8. Diabetes Examples Figure 9. Central Nervous System and Neurological Disorders Examples Figure 10. Endocrinology Examples Figure 11. Other Therapeutic Applications Examples Figure 12. Global Active Pharma Ingredient Sales, (US$ Million), 2016 VS 2021 VS 2027 Figure 13. Global Active Pharma Ingredient Sales Growth Rate (2016-2027) & (US$ Million) Figure 14. Global Active Pharma Ingredient Sales (K Pcs) Growth Rate (2016-2027) Figure 15. Global Active Pharma Ingredient Price Trends Growth Rate (2016-2027) (USD/Pcs) Figure 16. Global Active Pharma Ingredient Revenue Market Share by Region: 2016 VS 2021 Figure 17. Global Active Pharma Ingredient Revenue Market Share by Region: 2021 VS 2027 Figure 18. North America Active Pharma Ingredient Revenue (Million USD) Growth Rate (2016-2027) Figure 19. North America Active Pharma Ingredient Sales (K Pcs) Growth Rate (2016-2027) Figure 20. Europe Active Pharma Ingredient Revenue (Million USD) Growth Rate (2016-2027) Figure 21. Europe Active Pharma Ingredient Sales (Million USD) Growth Rate (2016-2027) Figure 22. China Active Pharma Ingredient Revenue (Million USD) Growth Rate (2016-2027) Figure 23. China Active Pharma Ingredient Sales (Million USD) and Growth Rate (2016-2027) Figure 24. Japan Active Pharma Ingredient Revenue (Million USD) Growth Rate (2016-2027) Figure 25. Japan Active Pharma Ingredient Sales (Million USD) Growth Rate (2016-2027) Figure 26. Southeast Asia Active Pharma Ingredient Revenue (Million USD) Growth Rate (2016-2027) Figure 27. Southeast Asia Active Pharma Ingredient Sales (Million USD) Growth Rate (2016-2027) Figure 28. India Active Pharma Ingredient Revenue (Million USD) Growth Rate (2016-2027) Figure 29. India Active Pharma Ingredient Sales (Million USD) Growth Rate (2016-2027) Figure 30. Global 5 Largest Active Pharma Ingredient Players Market Share by Revenue in Active Pharma Ingredient: 2016 & 2020 Figure 31. Active Pharma Ingredient Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020 Figure 32. Global Active Pharma Ingredient Revenue Share by Type (2016-2021) Figure 33. Global Active Pharma Ingredient Revenue Growth Rate by Type in 2016 & 2020 Figure 34. Global Active Pharma Ingredient Revenue Share by Application (2016-2021) Figure 35. Global Active Pharma Ingredient Revenue Growth Rate by Application in 2016 & 2020 Figure 36. North America Active Pharma Ingredient Sales Market Share by Type in 2020 Figure 37. North America Active Pharma Ingredient Sales Market Share by Application in 2020 Figure 38. Europe Active Pharma Ingredient Sales Market Share by Type in 2020 Figure 39. Europe Active Pharma Ingredient Sales Market Share by Application in 2020 Figure 40. China Active Pharma Ingredient Sales Market Share by Type in 2020 Figure 41. China Active Pharma Ingredient Sales Market Share by Application in 2020 Figure 42. Japan Active Pharma Ingredient Sales Market Share by Type in 2020 Figure 43. Japan Active Pharma Ingredient Sales Market Share by Application in 2020 Figure 44. Southeast Asia Active Pharma Ingredient Sales Market Share by Type in 2020 Figure 45. Southeast Asia Active Pharma Ingredient Sales Market Share by Application in 2020 Figure 46. India Active Pharma Ingredient Sales Market Share by Type in 2020 Figure 47. India Active Pharma Ingredient Sales Market Share by Application in 2020 Figure 48. Key Raw Materials Price Trend Figure 49. Manufacturing Cost Structure of Active Pharma Ingredient Figure 50. Manufacturing Process Analysis of Active Pharma Ingredient Figure 51. Active Pharma Ingredient Industrial Chain Analysis Figure 52. Channels of Distribution Figure 53. Distributors Profiles Figure 54. Bottom-up and Top-down Approaches for This Report Figure 55. Data Triangulation Figure 56. Key Executives Interviewed

Teva Novartis Pfizer Johnson & Johnson Mylan North China Pharmaceutical Group Dr. Reddy’s Laboratories Roche Aurobindo pharma Sun Pharmaceutical Industries Boehringer Ingelheim GmbH Bayer BASF DSM Zhejiang Medicine Biocon Johnson Matthey Hisun Pharmacy Cambrex Shandong Xinhua Pharmaceutical Lonza group Huahai Pharmaceutical Haerbin Pharmaceutical Group Cipla Tian Yao Lupin North East Pharmaceutical Albemarle Shandong Lukang Pharmaceutical Jiangsu Hengrui Medicine